Endometriosis
Drug research and approvals for endometriosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 161 studies of endometriosis are recruiting on ClinicalTrials.gov, Health Canada has authorized 11 drug trials for it since 2013, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 161
- Trials authorized in Canada: 11
- FDA orphan approvals: 0
- EU medicines: 2
Recruiting Now
Newest start dates first, of 161 recruiting on ClinicalTrials.gov ↗- Combined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic PainNCT07933094 · Not applicable · SWIMS America Corp. · starts Nov 1, 2026
- Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisNCT07755956 · Phase 1 · Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. · starts Oct 31, 2026
- Trial Evaluating Nutritional Fiber in Digestive Symptoms of EndometriosisNCT07875062 · Not applicable · LOAM Science · starts Oct 20, 2026
- The Impact of Yoga on Endometriosis-Related PainNCT06559852 · Not applicable · Milton S. Hershey Medical Center · starts Oct 15, 2026
- Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic SurgeryNCT07860203 · Not applicable · Catherin Zhang · starts Oct 1, 2026
- Study on the Ultrasound and Biological Characteristics of Atypical Endometriosis.NCT07816133 · Not reported · Casa di Cura Dott. Pederzoli · starts Oct 1, 2026
- Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With EndometriosisNCT07876648 · Not applicable · Universitaire Ziekenhuizen KU Leuven · starts Sep 30, 2026
- Assessment of Ovarian Reserve in the Treatment of Ovarian Endometrioma With Cystectomy or Argon Plasma CoagulationNCT07666412 · Not applicable · IRCCS Azienda Ospedaliero-Universitaria di Bologna · starts Sep 8, 2026
- Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic PainNCT07728695 · Phase 1 / Phase 2 · Staci Gruber, Ph.D. · starts Sep 1, 2026
- Artificial Intelligence Into Ultrasound Diagnostics in Reproductive MedicineNCT07810920 · Not reported · Semmelweis University · starts Sep 1, 2026
Trials Authorized in Canada
The 10 newest of 11; search them all in Canada trials| Dec 14, 2020 | A randomized, double-blind, open for active comparator, parallel-group, multicenter phase 2b study to access the efficacy and safety of three different doses…BAY 1817080 | Bayer | Closed |
| May 29, 2019 | A phase 3 multicenter, randomized, double-blind, placebo-controlled, clinical study to assess the efficacy and safety of linzagolix in subjects with moderate…LINZAGOLIX/ ESTRADIOL-NORETHINDRONE | OBSEVA S.A | Closed |
| Nov 9, 2018 | Spirit extension: an international phase 3 open-label, single-arm, safety and efficacy extension study to evaluate relugolix co-administered with low-dose…RELUGOLIX/ ESTRADIOL-NORETHINDRONE | MYOVANT SCIENCES GMBH | Closed |
| May 24, 2018 | A randomized, double-blind, parallel-group, mutlicenter phase 2b study to assess the efficacy and safety of two different doses of vilaprisan (bay 1002670)…VILAPRISAN (BAY 1002670) | Bayer | Closed |
| Dec 28, 2017 | A study to evaluate safety and efficacy of elagolix alone or elagolix with hormonal add-back in subjects with endometriosis with associated moderate to severe…ELAGOLIX/ ESTRADIOL-NORETHINDRONE ACETATE | AbbVie | Pending |
| Nov 9, 2017 | Spirit 2: an international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix administered with and without…RELUGOLIX/ ESTRADIOL-NORETHINDRONE | MYOVANT SCIENCES GMBH | Ongoing |
| Nov 9, 2017 | Spirit 1: an international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix administered with and without…RELUGOLIX/ ESTRADIOL-NORETHINDRONE | MYOVANT SCIENCES GMBH | Closed |
| Jul 24, 2017 | A phase 3 study to evaluate the safety and efficacy of elagolix in combination with estradiol/norethindrone acetate in subjects with moderate to severe…ELAGOLIX (ABT-620)/ ESTRADIOL-NORETHINDRONE ACETATE | AbbVie | Closed |
| Dec 19, 2014 | A randomized, double-blind, double-dummy, parallel- group, multi-center phase IIb study to assess the efficacy and safety of different dose combinations of an…BAY 98-7196 (ANASTROZOLE-LEVONROGESTREL) | Bayer | Closed |
| Oct 17, 2013 | Statins: a new therapeutic option for treatment of patients with endometriosisPRAVASTATIN/ UBIQUINOL | DR ROBERT F CASPER | Pending |
Medicines Authorised in the EU
Newest first| Jun 14, 2022 | Yseltylinzagolix choline | Theramex Ireland Limited | EMA ↗ |
| Jul 16, 2021 | Ryeqorelugolix;estradiol;norethisterone acetate | Gedeon Richter Plc. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA